Drugs that contain Edaravone
1. Radicava patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6933310 | MITSUBISHI TANABE | Therapeutic agent for amyotrophic lateral sclerosis (ALS) |
Nov, 2020
(3 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-144) | May 05, 2024 |
| ODE*(ODE*) | May 05, 2024 |
| New Chemical Entity Exclusivity(NCE) | May 05, 2022 |
| Orphan Drug Exclusivity(ODE) | May 05, 2024 |
NCE-1 date: 05 May, 2021
Market Authorisation Date: 05 May, 2017
Treatment: Treatment of amyotrophic lateral sclerosis (als)
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
RADICAVA family patents
2. Radicava Ors patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11478450 | MITSUBISHI TANABE | Edaravone suspension for oral administration |
Nov, 2039
(15 years from now) | |
| US11241416 | MITSUBISHI TANABE | Edaravone suspension for oral administration |
Nov, 2039
(15 years from now) | |
| US10987341 | MITSUBISHI TANABE | Edaravone suspension for oral administration |
Nov, 2039
(15 years from now) | |
| US11826352 | MITSUBISHI TANABE | Edaravone suspension for oral administration |
Nov, 2039
(15 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-144) | May 12, 2029 |
| New Product(NP) | May 12, 2025 |
Market Authorisation Date: 12 May, 2022
Treatment: Treatment of amyotrophic lateral sclerosis
Dosage: SUSPENSION;ORAL
How can I launch a generic of RADICAVA ORS before it's drug patent expiration?
More Information on Dosage
RADICAVA ORS family patents